Andersons pediatric cardiology 147

Dystrophingenotype-cardiacphenotype
correlationsinDuchenneandBeckermuscular
dystrophiesusingcardiacmagneticresonance
imaging.AmJCardiol.2015;115:967–971.
116.LimKR,MaruyamaR,YokotaT.Eteplirsenin
thetreatmentofDuchennemusculardystrophy.
DrugDesDevelTher.2017;11:533–545.
117.Duchennemusculardystrophy,genetics,the
FDAanddrugpricing.JAssocGenetTechnol.
2017;43:53–55.
118.MendellJR,SahenkZ,Rodino-KlapacLR.
ClinicaltrialsofexonskippinginDuchenne
musculardystrophy.ExpertOpiniononOrphan
Drugs.2017;1–8.
119.MignoneF,GissiC,LiuniS,PesoleG.
UntranslatedregionsofmRNAs.GenomeBiol.
2002;3[REVIEWS0004].
120.ScheperGC,vanderKnaapMS,ProudCG.
Translationmatters:Proteinsynthesisdefectsin
inheriteddisease.NatRevGenet.2007;8:711–
723.
121.NonnenmacherL,LangerT,BlessingH,etal.
Hereditaryhyperferritinemiacataractsyndrome:
Clinical,genetic,andlaboratoryfindingsin5
families.KlinPadiatr.2011;223:346–351.
122.CazzolaM,SkodaRC.Translational
pathophysiology:Anovelmolecularmechanism


ofhumandisease.Blood.2000;95:3280–3288.
123.KozakM.Emerginglinksbetweeninitiationof

translationandhumandiseases.MammGenome.
2002;13:401–410.
124.StoneleyM,ChappellSA,JoplingCL,etal.CMycproteinsynthesisisinitiatedfromthe
internalribosomeentrysegmentduring
apoptosis.MolCellBiol.2000;20:1162–1169.
125.LiuL,DilworthD,GaoL,etal.Mutationofthe
CDKN2A5’UTRcreatesanaberrantinitiation
codonandpredisposestomelanoma.NatGenet.
1999;21:128–132.
126.BowlesNE,KearneyDL,NiJ,etal.The
detectionofviralgenomesbypolymerasechain
reactioninthemyocardiumofpediatricpatients
withadvancedHIVdisease.JAmCollCardiol.
1999;34:857–865.
127.PalermoJ,GulickJ,ColbertM,FewellJ,
RobbinsJ.Transgenicremodelingofthe
contractileapparatusinthemammalianheart.
CircRes.1996;78:504–509.
128.PalermoJ,GulickJ,NgW,etal.Remodelingthe
mammalianheartusingtransgenesis.CellMol
BiolRes.1995;41:501–509.
129.McLendonPM,RobbinsJ.Desmin-related
cardiomyopathy:Anunfoldingstory.AmJ
PhysiolHeartCircPhysiol.2011;301:H1220–


H1228.
130.SchubertU,AntónLC,GibbsJ,etal.Rapid
degradationofalargefractionofnewly
synthesizedproteinsbyproteasomes.Nature.

2000;404:770–774.
131.ChristiansES,IshiwataT,BenjaminIJ.Small
heatshockproteinsinredoxmetabolism:
Implicationsforcardiovasculardiseases.IntJ
BiochemCellBiol.2012;44:1632–1645.
132.DoroudgarS,GlembotskiCC.Newconceptsof
endoplasmicreticulumfunctionintheheart:
Programmedtoconserve.JMolCellCardiol.
2013;55:85–91.
133.WillisMS,PattersonC.Intotheheart:The
emergingroleoftheubiquitin-proteasome
system.JMolCellCardiol.2006;41:567–579.
134.WillisMS,Townley-TilsonWHD,KangEY,
HomeisterJW,PattersonC.Senttodestroy:The
ubiquitinproteasomesystemregulatescell
signalingandproteinqualitycontrolin
cardiovasculardevelopmentanddisease.Circ
Res.2010;106:463–478.
135.WangX,RobbinsJ.Proteasomalandlysosomal
proteindegradationandheartdisease.JMolCell
Cardiol.2014;71:16–24.
136.AdamsJ.Theproteasome:Structure,function,
androleinthecell.CancerTreatRev.